BiotechTube
Home/Pipeline/Exelya®

Exelya®

Not Specified

PipelineTechnology Asset

Key Facts

Indication
Not Specified
Phase
Pipeline
Status
Technology Asset
Company
APR Applied Pharma Research

About APR Applied Pharma Research

APR Applied Pharma Research is a mission-driven Swiss pharma company focused on improving the lives of patients with rare diseases through innovative, patent-protected products. The company has successfully built a portfolio of marketed products, including PKU GOLIKE® and Nexodyn®, and maintains a promising clinical pipeline. Its strategy integrates direct commercialization in key European markets with a global partner network and a complementary CDMO services division, creating a diversified and resilient business.

View full company profile

Therapeutic Areas

Inherited Metabolic DisordersRare Dermatological DiseasesAdvanced Wound CareCancer Supportive CareOcular Diseases

Other Not Specified Drugs

DrugCompanyPhase
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
Collaborative Program with FerringPharmaBiomeResearch
Lighthouse Pilot ProductCipheromePilot
Nitric Oxide + Collagen DeliveryJellagenResearch
UndisclosedAutheraPre-clinical
BP1003Bio-Path HoldingsPreclinical
mRNA Therapeutics Platform ApplicationLupagenResearch
PHYRAGOHanda PharmaceuticalsApproved
TASCENSO ODTHanda PharmaceuticalsApproved
AxulinHousey Pharmaceutical Research LaboratoriesCommercial
PBI-04711Phoenix BiotechnologyPre-clinical